End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 CNY | 0.00% | -2.79% | +12.37% |
Mar. 26 | Court Dismisses Winding-Up Petition Against Kangmei Pharma's Unit | MT |
Oct. 27 | Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Sales 2021 | 4.15B 575M | Sales 2022 | 4.18B 578M | Capitalization | 30.5B 4.22B |
---|---|---|---|---|---|
Net income 2021 | 7.92B 1.1B | Net income 2022 | -2.69B -372M | EV / Sales 2021 | 9.78 x |
Net cash position 2021 | 2.21B 306M | Net cash position 2022 | 1.24B 172M | EV / Sales 2022 | 7 x |
P/E ratio 2021 |
5.42
x | P/E ratio 2022 |
-11.6
x | Employees | 6,371 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 66.8% |
1 day | -2.34% | ||
1 week | -2.79% | ||
Current month | +11.17% | ||
1 month | +9.42% | ||
3 months | +12.97% | ||
6 months | +13.59% | ||
Current year | +12.37% |
Managers | Title | Age | Since |
---|---|---|---|
Guo Wei Liu
CEO | Chief Executive Officer | 51 | 20-10-09 |
Gui Bo Gong
DFI | Director of Finance/CFO | 50 | 20-10-09 |
Min Li
IRC | Investor Relations Contact | 35 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Ping Lai
BRD | Director/Board Member | 63 | 20-10-29 |
Yan Zhu Gao
CHM | Chairman | 59 | 20-10-29 |
Qi Mi
BRD | Director/Board Member | 62 | 22-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2,761 M€ | +4.87% | - | |
0.00% | 429 M€ | +2.70% | - | |
0.00% | 147 M€ | +1.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 2.09 | 0.00% | 167 304 700 |
24-03-27 | 2.09 | -2.34% | 162,371,200 |
24-03-26 | 2.14 | -3.60% | 261,493,000 |
24-03-25 | 2.22 | -0.45% | 339,702,900 |
24-03-22 | 2.23 | +5.19% | 255,506,200 |
End-of-day quote Shanghai S.E., March 26, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.37% | 4.01B | |
+35.79% | 701B | |
+26.24% | 571B | |
+1.10% | 381B | |
+20.45% | 334B | |
+16.96% | 319B | |
+0.89% | 210B | |
+2.32% | 210B | |
-6.36% | 201B | |
-3.25% | 157B |